Literature DB >> 23553538

Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation.

Xiomara Q Rosales1, Vinod Malik, Amita Sneh, Lei Chen, Sarah Lewis, Janaiah Kota, Julie M Gastier-Foster, Caroline Astbury, Rob Pyatt, Shalini Reshmi, Louise R Rodino-Klapac, K Reed Clark, Jerry R Mendell, Zarife Sahenk.   

Abstract

INTRODUCTION: Recent in vitro studies suggest that CAPN3 deficiency leads initially to accelerated myofiber formation followed by depletion of satellite cells (SC). In normal muscle, up-regulation of miR-1 and miR-206 facilitates transition from proliferating SCs to differentiating myogenic progenitors.
METHODS: We examined the histopathological stages, Pax7 SC content, and muscle-specific microRNA expression in biopsy specimens from well-characterized LGMD 2A patients to gain insight into disease pathogenesis.
RESULTS: Three distinct stages of pathological changes were identified that represented the continuum of the dystrophic process from prominent inflammation with necrosis and regeneration to prominent fibrosis, which correlated with age and disease duration. Pax7-positive SCs were highest in the fibrotic group and correlated with down-regulation of miR-1, miR-133a, and miR-206.
CONCLUSIONS: These observations, and other published reports, are consistent with microRNA dysregulation leading to inability of Pax7-positive SCs to transit from proliferation to differentiation. This results in impaired regeneration and fibrosis.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553538      PMCID: PMC3634894          DOI: 10.1002/mus.23669

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  33 in total

1.  MicroRNA-1 and microRNA-206 improve differentiation potential of human satellite cells: a novel approach for tissue engineering of skeletal muscle.

Authors:  Merel Koning; Paul M N Werker; Daisy W J van der Schaft; Ruud A Bank; Martin C Harmsen
Journal:  Tissue Eng Part A       Date:  2011-12-20       Impact factor: 3.845

2.  miR-206 and -486 induce myoblast differentiation by downregulating Pax7.

Authors:  Bijan K Dey; Jeffrey Gagan; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

3.  MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway.

Authors:  Davide Cacchiarelli; Julie Martone; Erika Girardi; Marcella Cesana; Tania Incitti; Mariangela Morlando; Carmine Nicoletti; Tiziana Santini; Olga Sthandier; Laura Barberi; Alberto Auricchio; Antonio Musarò; Irene Bozzoni
Journal:  Cell Metab       Date:  2010-08-19       Impact factor: 27.287

4.  Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy.

Authors:  Ning Liu; Svetlana Bezprozvannaya; John M Shelton; Madlyn I Frisard; Matthew W Hulver; Ryan P McMillan; Yaru Wu; Kevin A Voelker; Robert W Grange; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

5.  Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3.

Authors:  Natalia Ermolova; Elena Kudryashova; Marino DiFranco; Julio Vergara; Irina Kramerova; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2011-05-30       Impact factor: 6.150

6.  Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles.

Authors:  Koichi Ojima; Yasuko Ono; Coen Ottenheijm; Shoji Hata; Hidenori Suzuki; Henk Granzier; Hiroyuki Sorimachi
Journal:  J Mol Biol       Date:  2011-02-03       Impact factor: 5.469

7.  microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice.

Authors:  Ning Liu; Andrew H Williams; Johanna M Maxeiner; Svetlana Bezprozvannaya; John M Shelton; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

8.  Down-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblasts.

Authors:  Pascal Stuelsatz; Frédéric Pouzoulet; Yann Lamarre; Elise Dargelos; Sylvie Poussard; Serge Leibovitch; Patrick Cottin; Philippe Veschambre
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

9.  microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7.

Authors:  Jian-Fu Chen; Yazhong Tao; Juan Li; Zhongliang Deng; Zhen Yan; Xiao Xiao; Da-Zhi Wang
Journal:  J Cell Biol       Date:  2010-09-06       Impact factor: 10.539

10.  Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.

Authors:  Simona Greco; Marco De Simone; Claudia Colussi; Germana Zaccagnini; Pasquale Fasanaro; Mario Pescatori; Rosanna Cardani; Riccardo Perbellini; Eleonora Isaia; Patrizio Sale; Giovanni Meola; Maurizio C Capogrossi; Carlo Gaetano; Fabio Martelli
Journal:  FASEB J       Date:  2009-06-15       Impact factor: 5.191

View more
  13 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

Review 2.  Molecular Therapies for Muscular Dystrophies.

Authors:  Ava Y Lin; Leo H Wang
Journal:  Curr Treat Options Neurol       Date:  2018-06-21       Impact factor: 3.598

Review 3.  Restoring the regenerative balance in neuromuscular disorders: satellite cell activation as therapeutic target in Pompe disease.

Authors:  Gerben J Schaaf; Rodrigo Canibano-Fraile; Tom J M van Gestel; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Ann Transl Med       Date:  2019-07

4.  A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.

Authors:  Jerry R Mendell; Zarife Sahenk; Vinod Malik; Ana M Gomez; Kevin M Flanigan; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Eric Meadows; Sarah Lewis; Lyndsey Braun; Kim Shontz; Maria Rouhana; Kelly Reed Clark; Xiomara Q Rosales; Samiah Al-Zaidy; Alessandra Govoni; Louise R Rodino-Klapac; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2014-10-17       Impact factor: 11.454

Review 5.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

6.  The miR-206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle.

Authors:  Thomas Boettger; Stas Wüst; Hendrik Nolte; Thomas Braun
Journal:  Skelet Muscle       Date:  2014-12-12       Impact factor: 4.912

7.  Lack of robust satellite cell activation and muscle regeneration during the progression of Pompe disease.

Authors:  Gerben J Schaaf; Tom J M van Gestel; Esther Brusse; Robert M Verdijk; Irenaeus F M de Coo; Pieter A van Doorn; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Acta Neuropathol Commun       Date:  2015-10-28       Impact factor: 7.801

Review 8.  A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups.

Authors:  Matthew E Randolph; Grace K Pavlath
Journal:  Front Aging Neurosci       Date:  2015-10-07       Impact factor: 5.750

9.  Editorial: Role of Stem Cells in Skeletal Muscle Development, Regeneration, Repair, Aging, and Disease.

Authors:  Pura Muñoz-Cánoves; Jaime J Carvajal; Adolfo Lopez de Munain; Ander Izeta
Journal:  Front Aging Neurosci       Date:  2016-04-28       Impact factor: 5.750

10.  Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases.

Authors:  Matthew S Alexander; Louis M Kunkel
Journal:  J Neuromuscul Dis       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.